OPKO Health, Inc. (OPK)
1.195
-0.04
(-3.63%)
USD |
NASDAQ |
Mar 03, 16:00
1.195
0.00 (0.00%)
After-Hours: 16:14
OPKO Health Research and Development Expense (Annual) : 124.03M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp. | 2.052B |
| AtriCure, Inc. | 90.17M |
| OrthoPediatrics Corp. | 9.102M |
| Solventum Corp. | 727.00M |
| Plus Therapeutics, Inc. | 10.58M |